Platelet aggregation and adhesion in diabetic foot: 616.379‐036.11‐07‐092:617.586
Тромбоз, гемостаз и реология

Tromboz, Gemostaz I Reologiya
scientific and practical journal

ISSN 2078–1008 (Print); ISSN 2687-1483 (online)

Keywords

type 2 diabetes mellitus
DM‐2
diabetic foot syndrome
DFS
platelet aggregation
endothelial dysfunction

Abstract

Summary. Introduction. Today, the most prevalent endocrine disease worldwide is diabetes mellitus (DM), which is increasing in prevalence at an alarming rate and has reached epidemic proportions. It is regarded as a principal predictor for macrovascular complications, which can lead to such formidable complications as diabetic foot. Aim: to assess the level of platelet aggregation and lymphocyte‐platelet adhesion in the development of diabetic foot syndrome (DFS). Materials and Methods. In a non‐randomized cohort retrospective study, three groups were formed. Group 1 included patients with type 2 diabetes mellitus (DM‐2) who did not develop diabetic foot (n = 29). Group 2 included 30 patients with DFS (n = 30). Group 3 included practically healthy individuals (n = 31). The aggregation ability of platelets was investigated through the assessment of the degree and rate of ADP‐induced platelet aggregation, as determined by the curve of the average aggregate size and the light transmission curve. The indicator of lymphocyte‐platelet adhesion was also determined and a lymphocyte‐platelet index was calculated. Results. The probability of DFS developing in patients with DM‐2 exhibiting a maximum degree of spontaneous platelet aggregation (SPAAMZ) of 1.84% or greater increases almost tenfold. The probability of DFS developing in patients with DM‐2 with a maximum value of light transmission during spontaneous platelet aggregation (SSPAMZ), which is 7.73% or less, increases almost threefold. The probability of DFS developing in patients with DM‐2 with a maximum value of light transmission during ADP‐induced platelet aggregation using an ADP solution at a concentration of 5 μg/mL (A5SPMS), which is 56.9% or more, increases by approximately 2.2 times. The probability of DFS developing in patients with DM‐2 with a maximum value of light transmission during ADP‐induced platelet aggregation using an ADP solution at a concentration of 1.25 μg/mL (A1SPMS), which is less than 47.5%, increases by approximately 5 times. The probability of DFS developing in patients with DM‐2 with a maximum degree of spontaneous platelet aggregation (SPAAMZ) of less than 60.7% increases approximately 1.4 times. Conclusion. DM‐2, complicated by diabetic foot development, is accompanied by pronounced changes in some platelet aggregation parameters. A comprehensive assessment of these changes allows predicting the risk of DFS.

For citation: Damdinov R.I., Shapovalov K.G., Troitskaya N.I., Solpov A.V. Platelet aggregation and adhesion in diabetic foot. Tromboz, gemostaz i reologiya. 2024;(3):67–74. (In Russ.).

References

  1. IDF Diabetes Atlas, 10th edition. Brussels: International Diabetes Federation, 2021. Available at: https://www.ncbi.nlm.nih.gov/ books/NBK581934/. [Accessed: 30.11.2023].
  2. Standards of medical care in diabetes‐2017: summary of revisions. Diabetes Care. 2017;40(Suppl 1):S4–S5. DOI: 10.2337/dc17‐S003.
  3. Type 1 diabetes mellitus: realities and prospects. Eds. I.I. Dedov, M.V. Shestakova. Moscow: MIA, 2016. 504 pp. (In Russ.).
  4. Akhmetova E.S., Lareva N.V., Mudrov V.A., Gergesova E.E. Features of pregnancy with gestational diabetes mellitus and prediction of diabetic fetopathy. Zhurnal akusherstva i zhenskih boleznej. 2017;66(4):14–24. (In Russ.). DOI: 10.17816/JOWD66414‐24.
  5. Dedov I.I., Shestakova M.V., Vikulova O.K. Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry. Saharnyj diabet. 2017;20(1):13–41. (In Russ.). DOI: 10.14341/DM8664.
  6. ShestakovaM.V., MokryshevaN.G., DedovI.I.Course and treatment of diabetes mellitus in the context of COVID‐19. Saharnyj diabet. 2020;23(2):132–9. (In Russ.). DOI: 10.14341/DM12418.
  7. ShimkoV.V.,SakharyukA.P.,ReshetnikovaL.K.etal.Diabeticfoot, ways to improve treatment results. Byulleten’ Vostochno‐Sibirskogo nauchnogo centra Sibirskogo otdeleniya Rossijskoj akademii medicinskih nauk. 2012;(S4):114. (In Russ.).
  8. Presnyakova M.V., Kuznetsova V.L., Bobrov M.I., Kostina O.V. Hemostasis at acute inflammation in patients with neuroischemic form of «diabetic foot» syndrome. Tromboz, gemostaz i reologiya. 2018;(2):20–8. (In Russ.). DOI: 10.25555/THR.2018.2.0832.
  9. Dedov I.I. Diabetes mellitus: development of technologies in diagnostics, treatment and prevention. Saharnyj diabet. 2010;(3):6–13. (In Russ.). DOI: 10.14341/2072‐0351‐5480.
  10. Obolensky V.N., Nikitin V.G., Leval P.Sh. et al. Medical and diagnostic algorithm for diabetic foot syndrome: standards and new technologies. RMZh. 2012;20(12):585–98. (In Russ.).
  11. Cherdanzev D.V., Nikolaeva L.P., Stepanenko A.V., KonstantinovE.P.The pathogenetic role of diabetic macroangiopathy: the possible versions of correction. Fundamental’nye issledovaniya. 2010;(1):95–9. (In Russ.).
  12. BrodskiyI.N.,DeevR.V.Angiogenictherapyintreatmentofcritical limb ischemia. Trudnyj pacient. 2014;12(6):16–8. (In Russ.).
  13. Kozlovsky V.I., Kovtun O.M., Seroukhova O.P. et al. Study methods and clinical significance of platelet aggregation. Focus on spontaneous aggregation. Vestnik VGMU. 2013;12(4):79–91. (In Russ.).
  14. Roitman E.V., Raskurazhev A.A., Lagoda O.V. et al. Endothelial dysfunction, platelet aggregation and blood rheological properties in tobacco smokers. Tromboz, gemostaz i reologiya. 2022;(2):13– 22. (In Russ.). DOI: 10.25555/THR.2022.2.1015.
  15. Antonova K.V., Tanashyan M.M., Shabalina A.A. et al. Hemostasis in patients with type 2 diabetes mellitus and obesity in acute and chronic cerebrovascular pathology. Tromboz, gemostaz i reologiya. 2020;(2):60–7. (In Russ.). DOI: 10.25555/THR.2020.2.0919.
  16. Standards of specialized diabetes care. Eds. I.I. Dedov, M.V. Shestakova, A. Yu. Mayorov. 11th issue. Moscow, 2023. 158 pp. (In Russ.). DOI: 10.14341/DM13042.
  17. Vitkovsky Yu.A., Kuznik B.I., Solpov A.V. Phenomenon of lymphocyte‐thrombocyte rosette formation. Immunologiya. 1999;20(4): 35–7. (In Russ.).
  18. Mudrov V.A. Algorithms for statistical analysis of biomedical research data using the SPSS software package (in plain language): a textbook. Moscow: Logosfera, 2022. 143 pp. (In Russ.).